nach oben

Erschienen in:

01.06.2016 | Original Article

¹⁸F-FDG uptake by rectal cancer is similar in mucinous and nonmucinous histological subtypes

verfasst von: Dalton A. dos Anjos, Angelita Habr-Gama, Bruna B. Vailati, Cecilia B. Rossi, Adelina E. Coturel, Rodrigo O. Perez, Guilherme P. São Julião, João B. de Sousa, Carlos A. Buchpiguel

Erschienen in: Annals of Nuclear Medicine | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

PET/CT has been considered limited for the evaluation of mucinous colorectal tumors due to low ¹⁸F-FDG uptake. The aim of our study was to compare PET/CT variables in mucinous (MC) and nonmucinous (NMC) rectal adenocarcinomas.

Methods

Consecutive patients with cT2-4N0-2M0 rectal cancer included in a prospective clinical trial were reviewed. PET/CT was performed for primary baseline staging. Visual and quantitative analysis included SUVmax and SUVmean, metabolic tumor volume (MTV) and total lesion glycolysis (TLG). PET/CT parameters were compared according to histological subtypes.

Results

Overall, 73 patients were included (18 mucinous and 55 nonmucinous). SUVmax values were similar between MC and NMC (19.7 vs. 16.6; p = 0.5). MTV and TLG values were greater in the MC group (103.9 vs. 54.1; p = 0.007 and 892.5 vs. 358.8; p = 0.020) due to larger tumor volumes of MC.

Conclusions

Metabolic parameters at baseline PET/CT for patients with rectal cancer are similar in mucinous and nonmucinous histological subtypes.

Gallagher BM, Fowler JS, Gutterson NI, MacGregor RR, Wan C-N, Wolf AP. Metabolic trapping as a principle of radiopharmaceutical design: some factors responsible for the biodistribution of [18F] 2-deoxy-2-fluoro-d-glucose. J Nucl Med. 1978;19(10):1154–61.PubMed

Martoni AA, Di Fabio F, Pinto C, Castellucci P, Pini S, Ceccarelli C, et al. Prospective study on the FDG-PET/CT predictive and prognostic values in patients treated with neoadjuvant chemoradiation therapy and radical surgery for locally advanced rectal cancer. Ann Oncol. 2011;22(3):650–6. doi:10.1093/annonc/mdq433.CrossRefPubMed

Melton GB, Lavely WC, Jacene HA, Schulick RD, Choti MA, Wahl RL, et al. Efficacy of preoperative combined 18-fluorodeoxyglucose positron emission tomography and computed tomography for assessing primary rectal cancer response to neoadjuvant therapy. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2007;11(8):961–9. doi:10.1007/s11605-007-0170-7 (discussion 9).CrossRef

Perez RO, Habr-Gama A, Gama-Rodrigues J, Proscurshim I, Juliao GP, Lynn P, et al. Accuracy of positron emission tomography/computed tomography and clinical assessment in the detection of complete rectal tumor regression after neoadjuvant chemoradiation: long-term results of a prospective trial. Cancer. 2012;118(14):3501–11. doi:10.1002/cncr.26644 (National Clinical Trial 00254683).CrossRefPubMed

Cascini GL, Avallone A, Delrio P, Guida C, Tatangelo F, Marone P, et al. 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer. J Nucl Med. 2006;47(8):1241–8.PubMed

Hugen N, Brown G, Glynne-Jones R, de Wilt JH, Nagtegaal ID. Advances in the care of patients with mucinous colorectal cancer. Nat Rev Clin Oncol. 2015;. doi:10.1038/nrclinonc.2015.140.PubMed

Bosman FT. WHO classification of tumors of the digestive system. Lyon: IARC Press; 2010.

Whiteford MH, Whiteford HM, Yee LF, Ogunbiyi OA, Dehdashti F, Siegel BA, et al. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum. 2000;43(6):759–67 (discussion 67–70).CrossRefPubMed

Berger KL, Nicholson SA, Dehdashti F, Siegel BA. FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features. AJR Am J Roentgenol. 2000;174(4):1005–8. doi:10.2214/ajr.174.4.1741005.CrossRefPubMed

10.

Delbeke D, Martin WH. PET and PET-CT for evaluation of colorectal carcinoma. Semin Nucl Med. 2004;34(3):209–23. doi:10.1053/j.semnuclmed.2004.03.006.CrossRefPubMed

11.

O’Connor OJ, McDermott S, Slattery J, Sahani D, Blake MA. The use of PET-CT in the assessment of patients with colorectal carcinoma. Int J Surg Oncol. 2011;2011:846512. doi:10.1155/2011/846512.PubMedPubMedCentral

12.

Dewhurst C, Rosen MP, Blake MA, Baker ME, Cash BD, Fidler JL, et al. ACR appropriateness criteria pretreatment staging of colorectal cancer. J Am Coll Radiol. 2012;9(11):775–81. doi:10.1016/j.jacr.2012.07.025.CrossRefPubMed

13.

Gollub MJ, Grewal RK, Panu N, Thipphavong S, Sohn M, Zheng J, et al. Diagnostic accuracy of (1)(8)F-FDG PET/CT for detection of advanced colorectal adenoma. Clin Radiol. 2014;69(6):611–8. doi:10.1016/j.crad.2014.01.009.CrossRefPubMed

14.

Ozis SE, Soydal C, Akyol C, Can N, Kucuk ON, Yagci C, et al. The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the primary staging of rectal cancer. World J Surg Oncol. 2014;12:26. doi:10.1186/1477-7819-12-26.CrossRefPubMedPubMedCentral

15.

Yeh CL, Chen YK. Interesting image. Utility of FDG metabolism to differentiate synchronous metastatic liver lesions from synchronous colon cancer: nonmucinous versus mucinous adenocarcinoma. Clin Nucl Med. 2010;35(1):44–6. doi:10.1097/RLU.0b013e3181c361c4.CrossRefPubMed

16.

Ay MR, Zaidi H. Assessment of errors caused by X-ray scatter and use of contrast medium when using CT-based attenuation correction in PET. Eur J Nucl Med Mol Imaging. 2006;33(11):1301–13. doi:10.1007/s00259-006-0086-6.CrossRefPubMed

17.

Soret M, Bacharach SL, Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med. 2007;48(6):932–45. doi:10.2967/jnumed.106.035774.CrossRefPubMed

Titel: 18F-FDG uptake by rectal cancer is similar in mucinous and nonmucinous histological subtypes
verfasst von: Dalton A. dos Anjos
Angelita Habr-Gama
Bruna B. Vailati
Cecilia B. Rossi
Adelina E. Coturel
Rodrigo O. Perez
Guilherme P. São Julião
João B. de Sousa
Carlos A. Buchpiguel
Publikationsdatum: 01.06.2016
Verlag: Springer Japan
Erschienen in: Annals of Nuclear Medicine / Ausgabe 8/2016
Print ISSN: 0914-7187
Elektronische ISSN: 1864-6433
DOI: https://doi.org/10.1007/s12149-016-1089-4

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

¹⁸F-FDG uptake by rectal cancer is similar in mucinous and nonmucinous histological subtypes

Abstract

Purpose

Methods

Results

Conclusions

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2016

Preclinical and first-in-man studies of [11C]CB184 for imaging the 18-kDa translocator protein by positron emission tomography

Extrastriatal spreading of microglial activation in Parkinson’s disease: a positron emission tomography study

Impact of patient age on the iodine/FDG “flip-flop” phenomenon in lung metastasis from thyroid cancer

A two‐center study for the quality control of [18F]FDG using FASTlab phosphate cassettes

11C-methylaminoisobutyric acid (MeAIB) PET for evaluation of prostate cancer: compared with 18F-fluorodeoxyglucose PET

Effect of 18F-fluorodeoxyglucose extravasation on time taken for tumoral uptake to reach a plateau: animal and clinical PET analyses